Combination Therapy With GEN0101 and Pembrolizmub in Advanced Melanoma Patients PIb/PII
Status:
Recruiting
Trial end date:
2022-06-30
Target enrollment:
Participant gender:
Summary
This is a multi-center, open-labeled, non-randomized, single arm investigator-initiated trial
to evaluate the safety and efficacy of GEN0101 and Pembrolizmub combination in patients with
advanced melanoma.